From: The incretin effect in type 2 diabetes in a Sub-Saharan African population
Non-diabetes control n = 10 | T2D from HbA1c n = 10 | T2D from OGTT n = 10 | ||||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
Age (years) | 47.2 | ± 7.5 | 37.3 | ± 6.1 | 48.2 | ± 7.7 |
Males (%) | 60 | 10 | 60 | |||
Weight (kg) | 64.0 | ± 10.8 | 69.8 | ± 7.0 | 66.9 | ± 10.0 |
Body mass index (kg/m2) | 23.1 | ± 3.4 | 27.0 | ± 3.0 | 24.0 | ± 4.0 |
2 h OGTT glucose (mmol/l) | 7.5 | ± 1.2 | 7.3 | ± 0.5 | 13.1 | ± 4.5 |
HbA1c (mmol/mol) | 38.5 | ± 4.6 | 53.9 | ± 22.1 | 61.2 | ± 31.4 |
Anti-diabetes treatment (%) | 0 | 0 | 40 | |||
Median | IQR | Median | IQR | Median | IQR | |
Matsuda index | 6.5 | 4.2–12.8 | 5.6 | 2.6–7.2 | 7.9 | 5.0-10.2 |
HOMA-IR | 1.4 | 0.5–2.2 | 1.6 | 1.2-3.0 | 1.2 | 0.7–2.7 |
HOMA-beta | 21.7 | 12.6–42.2 | 37.6 | 24.3–76.7 | 15.5 | 9.1–22.7 |
Insulinogenic index | 73.1 | 50.5-127.1 | 220.2 | 158.1-378.2 | 32.2 | 22.1–81.4 |
Disposition index | 54.3 | 29.1-112.9 | 178.4 | 97.5–317.0 | 23.1 | 5.6–59.7 |